Table 3.
Unit | M1‐350 | M1‐200 | M1‐100 | M1‐50(A) | M1‐50(B) | M1‐50(C) | M1‐50(D) | M1‐50(E) | ||
---|---|---|---|---|---|---|---|---|---|---|
N patients | 350 | 200 | 100 | 50 | 50 | 50 | 50 | 50 | ||
N samples | 1,549 | 814 | 452 | 249 | 208 | 243 | 178 | 314 | ||
N cmt | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
|
L/hr | 3.98 (6.1%) | 3.8 (9.5%) | 3.53 (9.9%) | 3.96 | 4.15 (15%) | 3.32 (13%) | 3.76 | 3.56 | |
|
L | 87.7 (7.7%) | 93.8 (11%) | 80.1 (11%) | 83.5 | 64.8 (20%) | 76.1 (18%) | 87 | 73 | |
|
0.648 (7.7%) | 0.682 (12%) | 0.679 (10%) | 0.64 | 0.589 (21%) | 0.766 (12%) | 0.641 | 0.579 | ||
|
0.0622 (36%) | 0.0435 (66%) | 0.0617 (59%) | 0.0661 | 0.0814 (60%) | 0.0486 (110%) | 0.009 | 0.009 | ||
Prop. | % | 0.261 (3.1%) | 0.259 (4.4%) | 0.284 (5.7%) | 0.308 | 0.272 (5.1%) | 0.242 (8.7%) | 0.291 | 0.293 | |
Add. | mg/L | 1.68 (55%) | 1.79 (67%) | 2.08 (83%) | 0.0105 | 0.477 (190%) | 1.72 (160%) | 0.0105 | 1.48 | |
|
0.384 (4.3%) | 0.368 (6.7%) | 0.427 (7.4%) | 0.344 | 0.424 (16%) | 0.406 (12%) | 0.453 | 0.381 | ||
|
0.626 (3.5%) | 0.578 (5%) | 0.866 (4.1%) | 0.835 | 0.631 (8.7%) | 0.388 (14%) | 0.512 | 0.266 | ||
|
0.555 (11%) | 0.554 (17%) | 0.487 (13%) | 0.457 | 0.403 (16%) | 0.561 (21%) | 0.717 | 0.429 |
Values shown are estimates with the relative standard error (RSE) expressed in parentheses. Missing RSE values indicate the covariance step could not be performed in NONMEM.
SCR, serum creatinine; N cmt, number of compartments in the training data set; N patients, number of patients in the training data set; N samples, number of vancomycin serum levels in the training data set.